559
Participants
Start Date
May 31, 2013
Primary Completion Date
April 30, 2014
Study Completion Date
April 30, 2014
Lumacaftor Plus Ivacaftor Combination
Fixed dose combination tablet
Ivacaftor
Film-coated tablet
Placebo
Matching placebo tablet
Birmingham
Anchorage
Tucson
Little Rock
Fresno
La Jolla
Loma Linda
Long Beach
Los Angeles
Madera
Oakland
Palo Alto
Denver
Gainsville
Hollywood
Orlando
Tampa
Atlanta
Boise
Chicago
Park Ridge
Peoria
Baltimore
Boston
Ann Arbor
Kansas City
Bedford
Lebanon
Long Branch
Hawthorne
New York
Valhalla
Chapel Hill
Durham
Akron
Cincinnati
Dayton
Portland
Hershey
Knoxville
Austin
Tyler
Colchester
Charlottesville
Norfolk
Seattle
Morgantown
Madison
Broadmeadow
Westmead
Adelaide
Halifax
Vancouver
Ottawa
Toronto
Brno
Plzen-Bory
Prague
Strasbourg
Roscoff
Paris
Bron
Pierre-Bénite
Tübingen
Erlangen
Würzburg
Cologne
Leipzig
Berlin
Dublin
Tallaght
Florence
Ancona
Genova
Milan
Roma
Verona
Amsterdam
Nijmegen
Rotterdam
The Hague
Gothenburg
Stockholm
Uppsala
Belfast
Exeter
Southhampton
Nottingham
Birmingham
Vertex Pharmaceuticals Incorporated
INDUSTRY